{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:06:21Z","timestamp":1775142381930,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":999,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.fertnstert.2019.04.034","type":"journal-article","created":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T19:05:23Z","timestamp":1560884723000},"page":"534-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Independent serum markers of corpora lutea function after gonadotropin-releasing hormone agonist trigger and adjuvant low dose human chorionic gonadotropin in in\u00a0vitro fertilization"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6376-1187","authenticated-orcid":false,"given":"Leah","family":"Kaye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1937-4315","authenticated-orcid":false,"given":"Jeffrey","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn","family":"Neuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Nulsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Benadiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Engmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2019.04.034_bib1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","article-title":"The use of\u00a0gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in\u00a0vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective rando","volume":"89","author":"Engmann","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib2","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/humupd\/dmr008","article-title":"GnRH agonist for triggering of final oocyte maturation: time for a change of practice?","volume":"17","author":"Humaidan","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib3","first-page":"CD008046","article-title":"Gonadotropin-releasing hormone agonist versus hCG for\u00a0oocyte triggering in antagonist-assisted reproductive technology","author":"Youssef","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib4","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1210\/jcem-57-4-792","article-title":"Hormonal dynamics at midcycle: a reevaluation","volume":"57","author":"Hoff","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1210\/jcem-73-3-584","article-title":"Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. II. Progesterone receptor expression in luteinizing granulosa cells","volume":"73","author":"Chandrasekher","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib6","doi-asserted-by":"crossref","first-page":"E1428","DOI":"10.1210\/jc.2015-2312","article-title":"GnRH agonist triggering modulates PEDF to VEGF ratio inversely to hCG in granulosa cells","volume":"100","author":"Miller","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib7","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.fertnstert.2008.08.118","article-title":"Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: a rationale for OHSS reduction","volume":"91","author":"Cerrillo","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib8","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","volume":"20","author":"Humaidan","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib9","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1093\/humrep\/dei150","article-title":"A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists","volume":"20","author":"Kolibianakis","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib10","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.fertnstert.2012.03.015","article-title":"Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders","volume":"97","author":"Griffin","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.fertnstert.2007.06.030","article-title":"Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in\u00a0vitro fertilization","volume":"90","author":"Shapiro","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib12","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.fertnstert.2011.03.109","article-title":"Comparison of \u201ctriggers\u201d using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin","volume":"95","author":"Shapiro","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1472-6483(10)60612-8","article-title":"Rescue of corpus luteum function with peri-ovulatory hCG supplementation in IVF\/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study","volume":"13","author":"Humaidan","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib14","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.fertnstert.2008.12.042","article-title":"1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study","volume":"93","author":"Humaidan","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib15","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/humrep\/det249","article-title":"GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients","volume":"28","author":"Humaidan","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib16","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/humrep\/dei475","article-title":"Serum inhibin A, VEGF and TNF\u03b1 levels after triggering oocyte maturation with GnRH agonist compared with hCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial","volume":"21","author":"Babayof","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib17","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/0002-9378(73)90057-4","article-title":"Plasma human chorionic gonadotropin, estrone, estradiol, estriol, progesterone, and 17\u03b1-hydroxyprogesterone in human pregnancy","volume":"117","author":"Tulchinsky","year":"1973","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib18","series-title":"Clinical gynecologic endocrinology and infertility","author":"Fritz","year":"2011"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/09513590310001651795","article-title":"First trimester endocrinology: consequences for diagnosis and\u00a0treatment of pregnancy failure","volume":"18","author":"Schindler","year":"2004","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib20","first-page":"S92","article-title":"Plasma prorenin during early pregnancy: ovarian secretion under gonadotropin control?","volume":"4","author":"Sealey","year":"1986","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib21","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.1073\/pnas.84.20.7285","article-title":"Plasma prorenin response to\u00a0human chorionic gonadotropin in ovarian- hyperstimulated women: correlation with the number of ovarian follicles and steroid hormone concentrations","volume":"84","author":"Itskovitz","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1210\/jcem-65-2-349","article-title":"Source of plasma prorenin in early and late pregnancy: observations in a patient with primary ovarian failure","volume":"65","author":"Derkx","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib23","first-page":"906","article-title":"Highest concentrations of prorenin and human chorionic gonadotropin in gestational sacs during early human pregnancy","volume":"75","author":"Itskovitz","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/frne.1997.0152","article-title":"The ovarian renin-angiotensin system in reproductive physiology [Review]","volume":"18","author":"Yoshimura","year":"1997","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1210\/jcem-69-1-31","article-title":"Tissue levels of active and\u00a0total renin, angiotensinogen, human chorionic gonadotropin, estradiol, and progesterone in human placentas from different methods of delivery","volume":"69","author":"Lenz","year":"1989","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.conctc.2017.08.008","article-title":"The\u00a0Dual Trigger Study: rationale and study design of a prospective double-blind randomized clinical trial comparing pregnancy rates after co-administration of low dose hCG at the time of GnRH agonist trigger or\u00a035 h later for the prevention of OHSS","volume":"8","author":"Griffin","year":"2017","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13048-019-0483-7","article-title":"Low dose human chorionic gonadotropin administration at the time of gonadotropin-releasinghormone agonist trigger versus 35\u2009h later in women at high risk of developing ovarian hyperstimulation syndrome\u2014a prospective randomized double-blind clinical trial","volume":"12","author":"Engmann","year":"2019","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.fertnstert.2005.07.1292","article-title":"Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in\u00a0vitro fertilization cycles","volume":"85","author":"Papanikolaou","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","article-title":"Ovarian hyperstimulation syndrome: an update review","volume":"44","author":"Golan","year":"1989","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib30","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/humrep\/des361","article-title":"Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger","volume":"28","author":"Kummer","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib31","first-page":"906","article-title":"Highest concentrations of prorenin and human chorionic gonadotropin in gestational sacs during early human pregnancy","volume":"75","author":"Itskovitz","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib32","doi-asserted-by":"crossref","first-page":"8705","DOI":"10.1073\/pnas.82.24.8705","article-title":"Cyclical secretion of\u00a0prorenin during the menstrual cycle: synchronization with luteinizing hormone and progesterone","volume":"82","author":"Sealey","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0015-0282(16)54474-4","article-title":"Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist","volume":"56","author":"Itskovitz","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib34","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0002-9378(11)91576-2","article-title":"Influence of corpus luteum age on the\u00a0steroidogenic response to exogenous human chorionic gonadotropin in normal cycling women","volume":"167","author":"Fritz","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib35","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1210\/jc.2002-021916","article-title":"The steroidogenic response and corpus luteum expression of the steroidogenic acute regulatory protein after human chorionic gonadotropin administration at different times in\u00a0the human luteal phase","volume":"88","author":"Kohen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib36","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jcem.87.2.8197","article-title":"Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in\u00a0vitro fertilization","volume":"87","author":"Fauser","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2019.04.034_bib37","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000292612","article-title":"Origin of first\u00a0trimester 17-hydroxyprogesterone levels as determined in pregnancies by donor oocyte fertilization","volume":"36","author":"Check","year":"1993","journal-title":"Gynecol Obstet Invest"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028219304133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028219304133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:23:05Z","timestamp":1758010985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028219304133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0015028219304133"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2019.04.034","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Independent serum markers of corpora lutea function after gonadotropin-releasing hormone agonist trigger and adjuvant low dose human chorionic gonadotropin in in\u00a0vitro fertilization","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2019.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92019 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}